Xaluprine

Medicinal product

(Invented) name

Xaluprine

Active substance (s)

Merkaptopurinas

Strength

20 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BB02, Mercaptopurine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2024-08-27

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Oral suspension	1 ml
Merkaptopurinas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115224	101333	1101333	buteliukas	100 ml, buteliuko adapteris ir 2 dozavimo švirkštai N1		Receptinis	EU/1/11/727/001	Netiekiama	-	2025-12-31	No	-	-

Stadijos

Data	Stadija
2024-08-27	Registruotas